Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
904,203
-
Share change
-
-41,174
-
Total reported value
-
$150,401,896
-
Price per share
-
$166.33
-
Number of holders
-
110
-
Value change
-
-$6,729,554
-
Number of buys
-
42
-
Number of sells
-
33
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2024
As of 31 Mar 2024,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
904,203 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Miller Investment Management, LP, JPMORGAN CHASE & CO, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, COMMONWEALTH EQUITY SERVICES, LLC, Consolidated Investment Group LLC, Royal Bank of Canada, UBS Group AG, and LPL Financial LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.